Merit Puts a Bow On Cianna Medical Acquisition
Merit Medical Systems has completed the acquisition of Aliso Viejo, CA-based, Cianna Medical. The South Jordan, UT-based company put an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones.
Merit said that Cianna specializes in wire-free breast localization and has been focused on breast conservation for 11 years. Its research, development and commercialization teams developed a non-radioactive, wire-free breast localization system and technology that uses...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news
When Opioids for Cancer Pain Go Wrong: Clin Onc News Report
(MedPage Today) -- Also, breast-conserving surgery or mastectomy? (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - August 15, 2018 Category: OBGYN Source Type: news
Hologic buys Faxitron for $85M
Moving to expand its presence in the breast-conserving surgery market, women's...Read more on AuntMinnie.comRelated Reading:
Hologic appoints new CFO
Hologic wins $4.8M in patent lawsuit against Minerva
Judge finds in favor of Hologic in Fujifilm patent lawsuit
Faxitron acquires Precision X-Ray assets
FDA clears Faxitron's 3D CT breast system
Faxitron to double sales team in 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 2, 2018 Category: Radiology Source Type: news
Could Faxitron Really Be the Perfect Tuck-in for Hologic?
In a move to broaden and further strengthen its breast health portfolio, Hologic said it has acquired digital specialist Faxitron Bioptics for $85 million.
Tucson, AZ-based Faxitron markets a broad portfolio of products across major categories including digital specimen radiography, breast lesion localization, and sentinel lymph node biopsy. The company most recently launched the VisionCT. The technology is a 3-D breast specimen-designated CT system to offer 360-degree images of excised lesions.
“Faxitron's market-leading products, which span from digital specimen radiography to breast lesion localization...
Source: MDDI - August 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Potential New Surgical Options for Women with Multiple Ipsilateral Breast Cancer
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - July 16, 2018 Category: Hospital Management Authors: Geisel Communications Tags: News Research breast cancer Norris Cotton Cancer Center Source Type: news
Potential new surgical options for women with multiple ipsilateral breast cancer
(Dartmouth-Hitchcock Medical Center) Initial results of a new national clinical trial show that the majority of women with breast cancer who have two to three sites of disease in a single breast at the time of diagnosis are able to successfully complete breast-conserving surgery without conversion to mastectomy. This is the first prospective study to assess this possibility, and its findings improve the surgical choices available to women with multiple ipsilateral breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2018 Category: Cancer & Oncology Source Type: news
Meta-analysis: Recurrence Rates After Lumpectomy Have Improved Meta-analysis: Recurrence Rates After Lumpectomy Have Improved
More than ever before, breast-conserving surgery is a treatment option for more breast cancer patients, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Medicaid expansion in Kentucky improves breast cancer care for women 20 to 64 years old
(American College of Surgeons) In Kentucky, one of the Medicaid expansion states, a University of Louisville study of breast cancer care has found a connection between Medicaid expansion and improved quality of breast cancer care, including an increase in diagnosis of early stage disease and greater utilization of breast-conserving surgery instead of more invasive operations such as mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer.
The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue.
GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was based...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news
Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading:
ASTRO: Breast radiation 'less scary' than expected
JCO releases new sentinel node biopsy guidelines
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news
Why More Women Are Getting a Double Mastectomy
Recent research has shown that despite more having more treatment options, women with cancer in one breast are increasingly choosing to remove both breasts—even though experts in the field say the procedure is not necessarily accompanied by better outcomes.
Now, a new study published Wednesday in JAMA Surgery finds that the increase is being driven in part by their surgeons.
Doctors generally discourage contralateral prophylactic mastectomy—also known as CPM, or the removal of a healthy breast when the other has cancer—for women at an average risk for additional breast cancer. They do recommend it for wo...
Source: TIME.com: Top Science and Health Stories - September 13, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Breast Cancer breast cancer treatment contralateral prophylactic mastectomy double mastectomy lumpectomy symptoms breast cancer Source Type: news
Dune Medical relocates US HQ to Atlanta
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device.
The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the company said.
The system uses the company’s proprietary radiofrequency spectroscopy technology to help surgeons identify microscopic residual cancer at surgical margins during surgery.
“Dune’s proprietary technology is already demonstrating high value by ...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dune Medical Devices Inc. Source Type: news
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
(Wiley) A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news
